about
The NER proteins XPC and CSB, but not ERCC1, regulate the sensitivity to the novel DNA binder S23906: implications for recognition and repair of antitumor alkylators.SAGETTARIUS: a program to reduce the number of tags mapped to multiple transcripts and to plan SAGE sequencing stagesA compound heterozygote case of isolated sulfite oxidase deficiency.Cdx1 homeobox gene during human colon cancer progression.Targeted apc;twist double-mutant mice: a new model of spontaneous osteosarcoma that mimics the human diseasePrimary tumour genetic alterations and intra-tumoral heterogeneity are maintained in xenografts of human colon cancers showing chromosome instability.Synergistic antitumor effect between gefitinib and fractionated irradiation in anaplastic oligodendrogliomas cannot be predicted by the Egfr signaling activity.A model of postsurgical advanced metastatic breast cancer more accurately replicates the clinical efficacy of antiangiogenic drugs.Integrin α5β1 and p53 convergent pathways in the control of anti-apoptotic proteins PEA-15 and survivin in high-grade gliomaPreclinical recapitulation of antiangiogenic drug clinical efficacies using models of early or late stage breast cancer metastatis.Impact of EGFR mutations and KRAS amino acid substitution on the response to radiotherapy for brain metastasis of non-small-cell lung cancer.Integrin α5β1 plays a critical role in resistance to temozolomide by interfering with the p53 pathway in high-grade glioma.Pyridylthiourea-grafted polyethylenimine offers an effective assistance to siRNA-mediated gene silencing in vitro and in vivo.Involvement of the TGFβ pathway in the regulation of α5 β1 integrins by caveolin-1 in human glioblastoma.MET gene copy number in non-small cell lung cancer: molecular analysis in a targeted tyrosine kinase inhibitor naïve cohort.Acquired irinotecan resistance is accompanied by stable modifications of cell cycle dynamics independent of MSI status.Characterization of the transcriptional and metabolic responses of pediatric high grade gliomas to mTOR-HIF-1α axis inhibition.Role of Topoisomerases in Pediatric High Grade Osteosarcomas: TOP2A Gene Is One of the Unique Molecular Biomarkers of Chemoresponse.A cytogenetic study of 397 consecutive acute myeloid leukemia cases identified three with a t(7;21) associated with 5q abnormalities and exhibiting similar clinical and biological features, suggesting a new, rare acute myeloid leukemia entity.EGFR-TKI and lung adenocarcinoma with CNS relapse: interest of molecular follow-up.Prognostic significance of allelic imbalance at the c-kit gene locus and c-kit overexpression by immunohistochemistry in pediatric osteosarcomas.Allelotyping analyses of synchronous primary and metastasis CIN colon cancers identified different subtypes.Evidence for various 20q status using allelotyping, CGH arrays, and quantitative PCR in distal CIN colon cancers.Use of magnetic beads for plasma cell-free DNA extraction: toward automation of plasma DNA analysis for molecular diagnostics.CDX2 in congenital gut gastric-type heteroplasia and intestinal-type Meckel diverticulaGenetic Compensation in a Human Genomic DisorderModification of topoisomerase genes copy number in newly diagnosed childhood acute lymphoblastic leukemiaStromelysin-3 induction and interstitial collagenase repression by retinoic acid. Therapeutical implication of receptor-selective retinoids dissociating transactivation and AP-1-mediated transrepressionTranscriptional induction of stromelysin-3 in mesodermal cells is mediated by an upstream CCAAT/enhancer-binding protein element associated with a DNase I-hypersensitive siteGenetic heterogeneity in lung and colorectal carcinoma as revealed by microsatellite analysis in plasma or tumor tissue DNAAllelic imbalance at loci containing FGFR, FGF, c-Met and HGF candidate genes in non-small cell lung cancer sub-types, implication for progressionDosing and scheduling influence the antitumor efficacy of a phosphinic peptide inhibitor of matrix metalloproteinasesFrequent rearrangements and amplification of the CDX2 homeobox gene in human sporadic colorectal cancers with chromosomal instabilityGerm-line exon 21 EGFR mutations, V843I and P848L, in nonsmall cell lung cancer patientsSynergistic Anti-Tumor Effect of mTOR Inhibitors with Irinotecan on Colon Cancer Cells
P50
Q30981252-781DFB10-078C-408F-8801-877C6CCCB938Q33299820-72B4BE59-E2A6-4EA5-A4BB-EBF856A966CCQ33885230-CFA49EB8-F2B6-4F1D-A67F-F73404CAA3A6Q34230041-21EBC596-2EDC-49E4-9DF8-75DC5F85EF2FQ34398283-5361F085-7867-4068-9BFB-F138A57634F4Q34490295-963938C7-CEE5-45A2-A295-9D75CA3F16E4Q34848038-AA3D9DF8-3D96-4EFE-A5EC-F52C6DFDE1F0Q35101358-AD42C2D5-8C72-428B-A339-2D2969D1561CQ37179323-3FF8BB31-B656-4C89-BFA6-EE94BA609849Q38145835-88560D3B-4E80-4024-8788-894CE02523D8Q38937520-AD7AFD02-58D7-4688-8003-4FF0EB151085Q39347057-65268722-ED39-48F2-ABA6-CF280CB6439AQ39454503-965E9240-1831-4632-9BC3-D1396BB4AAFBQ39477404-28619B3D-AEE9-4E71-8979-A969F504230EQ40108065-5A87196E-44DD-4EB4-B8BB-AE7D7BE00D0FQ42436505-7E73DB96-04BE-403B-B04F-3209592DE8F1Q42654003-D98D9A45-906A-4976-A427-14F6D619C811Q43065457-BE2FC4B6-6E47-467F-9849-D174B4237C73Q43720192-EC068EB5-D64F-4A84-AC5A-7936A550EB81Q46139339-F5B2D9EE-1218-473E-9B91-9F7966ECB955Q46412797-ADF86413-A76F-4F62-A2BB-BE5157686CF1Q53340099-D13AADBF-BC24-4A86-B7D7-B82F23754CEAQ54485335-5683AF44-46F4-4A7D-900F-11123179BB7BQ54746968-CC5E4493-B746-4F6F-B38B-917AD3B77C91Q57124867-C544B67C-F64E-44D6-B0B3-D8D2B439CE1BQ62059316-F150B9C6-C57D-486D-8E28-57AA6A69B67BQ73149881-1027D860-2EAA-4D6F-B28F-93B4AAADBC2FQ73248228-1CB45C06-9CA5-4FDE-85B7-768CD24DB655Q73279961-C3119DED-3D0F-4D4F-A18A-0A0ED69EE164Q73311455-E05F9B30-894C-435E-BDF3-9D23124F60D3Q79258888-8A87FC8D-CFF4-4E60-B15A-1F19B445C5C1Q80896169-F869D088-9173-48F5-825A-F7A526D19A28Q83859921-1A7191C7-6243-4824-9137-3E940352711DQ85226950-AFD35E66-6640-41C3-9855-91AD0CEA6207Q90802209-9DAB9CAD-337B-424C-8CF1-317E9946C8EB
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Eric Guerin
@ast
Eric Guerin
@en
Eric Guerin
@es
Eric Guerin
@nl
type
label
Eric Guerin
@ast
Eric Guerin
@en
Eric Guerin
@es
Eric Guerin
@nl
prefLabel
Eric Guerin
@ast
Eric Guerin
@en
Eric Guerin
@es
Eric Guerin
@nl
P106
P1153
6603674790
P31
P496
0000-0003-1388-2834